A Survey of Melatonin in Dietary Supplement Products Sold in the United States
Drug Testing and Analysis · 2025-08 · 17 (8) · 1176-1185
DOI: 10.1002/dta.3823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, online erschienen am 31.10.2024. Verfasst von Rahul S Pawar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Office of Regulatory Science, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA. Hauptthemen laut MEDLINE: Melatonin, Dietary Supplements. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
In the United States, melatonin products are widely available as dietary supplements. During the past few decades, melatonin products have gained popularity primarily as a sleep aid, with a variety of product forms available for different age groups of consumers. Recent reports have highlighted a rise in melatonin ingestion among children reported to poison control centers. The increased use of melatonin‐containing products, the diversity in product forms, and reported label discrepancies has emphasized the need for additional research to better understand the marketplace. This work aims to measure melatonin content in products sold as dietary supplements and marketed for children, evaluate method performance across different product categories, and determine if product form has an impact on melatonin stability. One hundred ten (110) dietary supplement products labeled to contain melatonin and marketed towards children were purchased and analyzed using a targeted LC‐MS/MS method validated for the qualitative determination of serotonin and quantification of melatonin, N 1 ‐acetyl‐ N 2 ‐formyl‐5‐methoxykynuramine (AFMK), and N 1 ‐acetyl‐5‐methoxykynuramine (AMK). Melatonin was identified in 108 of 110 products (98%) with a median concentration of 1.2 mg/g (range: 0.017–130 mg/g) or 1.7 mg/serving (range: 0.042–50 mg/serving). Further, in the tested products, melatonin content ranged from 0% to 667% of the label declaration. This study provides evidence to inform safety assessments and investigate potential factors that may influence reported concentrations, such as product stability and matrix influences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Office of Regulatory Science, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.
- Joint Institute for Food Safety and Applied Nutrition (JIFSAN), University of Maryland, College Park, Maryland, USA.
ORCID-Profile: Rahul S Pawar
Zitieren
APA
Pawar, R. S., Coppin, J. P., Khanna, S., & Parker, C. H. (2025). A Survey of Melatonin in Dietary Supplement Products Sold in the United States. Drug Testing and Analysis, 17(8), 1176-1185. https://doi.org/10.1002/dta.3823
Vancouver
Pawar RS, Coppin JP, Khanna S, Parker CH. A Survey of Melatonin in Dietary Supplement Products Sold in the United States. Drug Testing and Analysis. 2025;17(8):1176-1185. doi:10.1002/dta.3823
BibTeX
@article{Pawar2025,
author = {Pawar, Rahul S and Coppin, Julia P and Khanna, Saara and Parker, Christine H},
title = {A Survey of Melatonin in Dietary Supplement Products Sold in the United States},
journal = {Drug Testing and Analysis},
year = {2025},
volume = {17},
number = {8},
pages = {1176--1185},
doi = {10.1002/dta.3823}
}
EUVIMED